Dane Andreeff bought $8,229 of HSDT
President and CEO at HELIUS MEDICAL TECHNOLOGIES, INC.. 1,284 shares at an average of $6.41, traded Nov 30, 2023, filed Feb 15, 2024.
Score components
- +25RoleCEO
- 0Trade size$8k at market
- +10Relative to holdingsHoldings up 215%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-24-008177, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 30, 2023 | POpen-market purchase Common Stockindirect: See footnote | +641 | $6.37 | $4,083 | 1,239 | Feb 15, 2024 |
| Dec 1, 2023 | POpen-market purchase Common Stockindirect: See footnote | +643 | $6.45 | $4,146 | 1,882 | Feb 15, 2024 |
Related signals
Other insiders at HELIUS MEDICAL TECHNOLOGIES, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | HSDTbuy HELIUS MEDICAL TECHNOLOGIES, INC. | Dane Andreeff President and CEO | $40k 5,000 shares | +37% | |
| 36Weak | HSDTbuy HELIUS MEDICAL TECHNOLOGIES, INC. | Dane Andreeff President and CEO | $26k 4,006 shares | +35% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.